The HillTube

The Hill's Genetic Testing Briefing

Rapid innovation in genetic testing is producing dramatic changes in care for 
such cancers as leukemia, colon cancer, and breast cancer. Join us for a discussion, Thursday, November 17, 2011, about 
the impact of this innovation on outcomes, side effects and utilization of resources. We will be livestreaming the event at 8:30 a.m.

Featuring remarks by:

Congressman Michael Burgess MD (R-Tex.), Vice Chair of the House Energy and Commerce Health Subcommittee

Congressman Charles Gonzalez (D-Tex.), Member of the House Energy and Commerce Health Subcommittee

Mara Bloom, Executive Director, Cancer Center, Massachusetts General Hospital

Marc Grodman, MD, President, CEO, Chairman, Bio-Reference Laboratories, Inc.

Bill McGivney, PhD, CEO, National Comprehensive Cancer Network

Simon Tripp, Senior Director, Battelle Memorial Institute




MATERIALS FROM THE BREAKFAST

Presentation 1

Presentation 2

Presentation 3